Recent Posts What Houston Patients Should Know About GLP1 Medications for Diabetes and Weight Management GLP1 receptor agonists, commonly known by brand names like Ozempic, Wegovy, Trulicity and Mounjaro, have become widely discussed for their dual benefits: helping control type 2 diabetes and, in many cases, enabling significant weight loss
IGF-1 peptides are not approved for human use, and their safety has not been established in long-term clinical trials
The weight loss and A1c results are unprecedented
Do not discard a vial just because it is a day or two past the BUD
As insurers, employers, and state programs reassess cost exposure, coverage policies continue to tighten particularly for weight loss alone